Matthew Herder, Dalhousie University

Research

Collaborative Ethnography Commercialization Policy Intellectual Property Law Life Sciences Semi-Structured Interviews Surveys University Research Drugs & Vaccines

Latest papers

The United States is driving a public health emergency of international concern.
BMJ (Clinical research ed.) · 2026 · first author
Competitive interdependence: A critical political economy of regulation during the COVID-19 pandemic.
Social science & medicine (1982) · 2026
Public sector innovation and the constraints of 'platform thinking': An account of Johnson & Johnson's adenoviral vector vaccines.
Social science & medicine (1982) · 2025

All 29 publications

Latest funding

Improving Infectious Disease Innovation Governance
CIHR · 2021 · Nominated PI
$375,000
Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization
CIHR · 2020 · Nominated PI
$49,952
Beyond Transparency in Pharmaceutical Research and Regulation
CIHR · 2017 · Nominated PI
$489,600

All 6 grants and awards

29 publications.

01

The United States is driving a public health emergency of international concern.

Herder M, Habibi R, Hassan F, Hill A

BMJ (Clinical research ed.)2026First author

DOI: 10.1136/bmj-2026-089474 PMID: 41881464

02

Competitive interdependence: A critical political economy of regulation during the COVID-19 pandemic.

Eren Vural I, Herder M, Graham JE

Social science & medicine (1982)2026

DOI: 10.1016/j.socscimed.2025.118759 PMID: 41494485

03

Public sector innovation and the constraints of 'platform thinking': An account of Johnson & Johnson's adenoviral vector vaccines.

Sariahmed K, Graham JE, Herder M, Morten CJ

Social science & medicine (1982)2025

DOI: 10.1016/j.socscimed.2025.118687 PMID: 41125018

04

Flexibility over rigor: stakeholder acceptance of the limitations of confirmatory studies following accelerated approval.

Fernandez Lynch H, Lee S, Herder M, Ross JS, Ramachandran R

Health affairs scholar2025

DOI: 10.1093/haschl/qxaf183 PMID: 41245507

05

Drug Decriminalization in British Columbia and Changes in Drug Crime and Opioid and Stimulant Harms.

Gaudreault A, Talarico R, Herder M, Myran DT

JAMA2025

DOI: 10.1001/jama.2025.3006 PMID: 40227738

06

'Our project, your problem?' A case study of the WHO's mRNA technology transfer programme in South Africa.

Herder M, Benavides X

PLOS global public health2024First author

DOI: 10.1371/journal.pgph.0003173 PMID: 39312552

07

How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines.

Bai I, Doshi P, Herder M

BMJ evidence-based medicine2024Senior author

DOI: 10.1136/bmjebm-2023-112475 PMID: 37898504

08

"A Most Equitable Drug": How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development.

Grundy Q, Campbell C, Ali R, Herder M, Holloway K

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics2024

DOI: 10.1017/jme.2024.51 PMID: 38818600

09

Extending the US Food and Drug Administration's Postmarket Authorities.

Fernandez Lynch H, Sachs RE, Lee S, Herder M, Ross JS, Ramachandran R

JAMA health forum2023

DOI: 10.1001/jamahealthforum.2023.1313 PMID: 37294583

10

US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics.

Eadie A, MacGregor A, Wallach J, Ross J, Herder M

BMJ evidence-based medicine2023Senior author

DOI: 10.1136/bmjebm-2022-112005 PMID: 36944478

Improving Infectious Disease Innovation Governance

Nominated PICIHR2021Chair: Applied Public Health Chair - General Pool

Principal investigators: Herder, Matthew

Keywords: Drugs & Vaccines; Equity; Infectious Diseases; Innovation Policy

$375,000

Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization

Nominated PICIHR2020Operating Grant: Knowledge Synthesis: COVID-19 in Mental Health & Substance Use

Principal investigators: Herder, Matthew; Bonn, Matthew A; Genge, Leah M; Wildeman, Sheila M

Keywords: Harm Reduction; Opioid Agonist Therapy; Opioid Crisis; Safe Supply

$49,952

Beyond Transparency in Pharmaceutical Research and Regulation

Nominated PICIHR2017Project Grant

Principal investigators: Herder, Matthew; Graham, Janice E; Lemmens, Trudo; Lexchin, Joel

Keywords: Drug Safety; Law; Pharmaceutical Policy; Regulation

$489,600

Innovation, collaboration and impact: promoting academic leadership on global poverty reduction

Co-investigatorSSHRC2012Connection Grants

Principal investigators: Sengupta, Mitu

Keywords: global poverty; global justice; millennium development goals; innovation; intellectual property rights

$46,370

Emerging health researchers and the commercialization of academic science

Nominated PICIHR2012Operating Grant - PA: Regional Partnership Program - Nova Scotia

Principal investigators: Herder, Matthew

Keywords: Collaborative Ethnography; Commercialization Policy; Intellectual Property Law; Life Sciences; Semi-Structured Interviews; Surveys; University Research

$5,755

Emerging health researchers and the commercialization of academic science

Nominated PICIHR2012Operating Grant - Priority Announcement: Ethics

Principal investigators: Herder, Matthew

Keywords: Collaborative Ethnography; Commercialization Policy; Intellectual Property Law; Life Sciences; Semi-Structured Interviews; Surveys; University Research

$242,770

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Family and Community Medicine
Pediatrics
Education
Clinical Public Health Division
Other

Co-authors at Dalhousie University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Abhimanyu Sud

Family and Community Medicine

1 shared papers, latest 2022

Trudo Lemmens

Clinical Public Health Division

1 shared papers, latest 2021

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Collaborative Ethnography Dear Professor Herder, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "The United States is driving a public health emergency of international concern." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Improving Infectious Disease Innovation Governance" (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Matthew Herder

Research

Latest papers

Latest funding

The United States is driving a public health emergency of international concern.

Competitive interdependence: A critical political economy of regulation during the COVID-19 pandemic.

Public sector innovation and the constraints of 'platform thinking': An account of Johnson & Johnson's adenoviral vector vaccines.

Flexibility over rigor: stakeholder acceptance of the limitations of confirmatory studies following accelerated approval.

Drug Decriminalization in British Columbia and Changes in Drug Crime and Opioid and Stimulant Harms.

'Our project, your problem?' A case study of the WHO's mRNA technology transfer programme in South Africa.

How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines.

"A Most Equitable Drug": How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development.

Extending the US Food and Drug Administration's Postmarket Authorities.

US Food and Drug Administration regulatory reviewer disagreements and postmarket safety actions among new therapeutics.

Improving Infectious Disease Innovation Governance

Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization

Beyond Transparency in Pharmaceutical Research and Regulation

Innovation, collaboration and impact: promoting academic leadership on global poverty reduction

Emerging health researchers and the commercialization of academic science

Emerging health researchers and the commercialization of academic science

Frequent collaborators

Janice Graham

Abhimanyu Sud

Sheila Wildeman

Quinn Grundy

Trudo Lemmens